|1.||Calvo-Pinilla, Eva: 4 articles (04/2015 - 11/2010)|
|2.||Kalinke, Ulrich: 4 articles (03/2015 - 11/2006)|
|3.||Ortego, Javier: 3 articles (04/2015 - 11/2010)|
|4.||Castillo-Olivares, Javier: 3 articles (04/2015 - 02/2014)|
|5.||Gubbins, Simon: 3 articles (04/2015 - 02/2014)|
|6.||Yanai, Yoshiaki: 3 articles (06/2011 - 01/2007)|
|7.||Mertens, Peter Paul Clement: 2 articles (04/2015 - 02/2014)|
|8.||de la Poza, Francisco: 2 articles (04/2015 - 02/2014)|
|9.||Volz, Asisa: 2 articles (09/2014 - 04/2011)|
|10.||Sutter, Gerd: 2 articles (09/2014 - 04/2011)|
|1.||Chronic Hepatitis C
01/01/2010 - "Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C."
07/01/2002 - "Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients."
11/01/1998 - "Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients."
01/01/2003 - "The concentration of type I interferon receptor (IFN-Rc) in the liver is a crucial factor in determining the efficacy of interferon (IFN) therapy in patients with chronic hepatitis C. "
01/01/2005 - "Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings."
|2.||Renal Cell Carcinoma (Grawitz Tumor)
05/01/2000 - "Serum soluble interferon alpha/beta receptor (s-IFN-receptor) levels were determined in renal cell carcinoma (RCC) patients to study the clinical significance of the measurement. "
05/01/1999 - "Expression of type I interferon receptor in renal cell carcinoma."
01/01/2007 - "Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis."
06/01/2011 - "Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma."
11/01/2011 - "Complex association analysis of copaxone (glatiramer acetate) immunotherapy efficacy with allelic polymorphism in the number of immune response genes, which encode interferone beta (IFNB1), transforming growth factor beta1 (TGFB1), interferone gamma (IFNG), tumor necrosis factor (TNF), interferon alpha/beta receptor 1 (IFNAR1), CC chemokine receptor 5 (CCR5), interleukin 7 receptor alpha subunit (IL7RA), cytotoxic T-lymphocyte antigen 4 (CTLA4) and HLA class II histocompatibility antigen beta chain (DRB1) was performed with APSampler algorithm for 285 multiple sclerosis patients of Russian ethnicity. "
|5.||Bacterial Infections (Bacterial Infection)
11/01/2012 - "Moreover, mice deficient in type I interferon receptor (IFNAR knockout [KO] mice) effectively cleared the secondary bacterial infection from their lungs, increased the recruitment of neutrophils, and demonstrated an enhanced innate expression of interleukin-17 (IL-17) relative to wild-type (WT) mice. "
|2.||Messenger RNA (mRNA)
|3.||Interferon-alpha (Interferon Alfa)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Transforming Growth Factor beta1 (TGF beta 1)
|6.||Interleukin-7 Receptor alpha Subunit
|7.||Interleukin-17 (Interleukin 27)
|8.||CCR5 Receptors (CCR5 Receptor)
|9.||Histocompatibility Antigens (Histocompatibility Antigen)
|10.||sorafenib (BAY 43-9006)
|2.||Transplantation (Transplant Recipients)